Authors: | O'brien, M. F.; Russo, P.; Motzer, R. J. |
Article Title: | Sunitinib therapy in renal cell carcinoma |
Keywords: | cancer survival; treatment outcome; treatment response; clinical trial; fatigue; sorafenib; bevacizumab; sunitinib; diarrhea; drug dose reduction; drug efficacy; drug safety; nonhuman; side effect; antineoplastic agents; alpha interferon; cancer adjuvant therapy; cancer patient; combined modality therapy; cancer immunotherapy; multiple cycle treatment; nausea; stomatitis; kidney carcinoma; kidney neoplasms; nephrectomy; high risk patient; asthenia; dyspnea; fever; lymphocytopenia; carcinoma, renal cell; pancreatitis; pazopanib; short survey; skin discoloration; clear cell carcinoma; hypothyroidism; indoles; pyrroles; amylase blood level; hand foot syndrome; triacylglycerol lipase blood level; influenza; cytopenia; amylase; triacylglycerol lipase; progression-free survival; rcc; heart ejection fraction; platelet-derived growth factor inhibitor; vascular endothelial growth factor inhibitor |
Journal Title: | BJU International |
Volume: | 101 |
Issue: | 11 |
ISSN: | 1464-4096 |
Publisher: | Wiley Blackwell |
Date Published: | 2008-06-01 |
Start Page: | 1339 |
End Page: | 1342 |
Language: | English |
DOI: | 10.1111/j.1464-410X.2008.07506.x |
PUBMED: | 18284408 |
PROVIDER: | scopus |
DOI/URL: | |
Notes: | --- - "Cited By (since 1996): 7" - "Export Date: 17 November 2011" - "CODEN: BJINF" - "Source: Scopus" |